Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey T Tucker

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Drug Development and Industrial Pharmacy|September 21, 2007
The effect of ethanol on the release of opioids from oral prolonged-release preparationsMalcolm Walden, Fiona A Nicholls, Kevin J Smith, et al.
Journal of Clinical Pharmacology|November 17, 2004
Assessment of in vivo CYP2D6 activity: differential sensitivity of commonly used probes to urine pHMahmut Ozdemir, Kim H Crewe, Geoffrey T Tucker, et al.
Fertility and Sterility|May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrateAmin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
British Journal of Clinical Pharmacology|February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an exampleGemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 20, 2004
Predicting the clearance of CYP2C9 substratesKaren Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2005
Changes in liver volume from birth to adulthood: a meta-analysisTrevor N Johnson, Geoffrey T Tucker, M Stuart Tanner, et al.
Clinical Pharmacokinetics|May 14, 2015
Erratum to: A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo DataFarzaneh Salem, Trevor N Johnson, Khaled Abduljalil, et al.
Current Drug Metabolism|November 6, 2007
Prediction of intestinal first-pass drug metabolismJiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 3, 2005
Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocolJiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
Clinical Pharmacokinetics|March 28, 2014
A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo dataFarzaneh Salem, Trevor N Johnson, Khaled Abduljalil, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Drug Development and Industrial Pharmacy|September 21, 2007
The effect of ethanol on the release of opioids from oral prolonged-release preparationsMalcolm Walden, Fiona A Nicholls, Kevin J Smith, et al.
Journal of Clinical Pharmacology|November 17, 2004
Assessment of in vivo CYP2D6 activity: differential sensitivity of commonly used probes to urine pHMahmut Ozdemir, Kim H Crewe, Geoffrey T Tucker, et al.
Fertility and Sterility|May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrateAmin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
British Journal of Clinical Pharmacology|February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an exampleGemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 20, 2004
Predicting the clearance of CYP2C9 substratesKaren Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2005
Changes in liver volume from birth to adulthood: a meta-analysisTrevor N Johnson, Geoffrey T Tucker, M Stuart Tanner, et al.
Clinical Pharmacokinetics|May 14, 2015
Erratum to: A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo DataFarzaneh Salem, Trevor N Johnson, Khaled Abduljalil, et al.
Current Drug Metabolism|November 6, 2007
Prediction of intestinal first-pass drug metabolismJiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 3, 2005
Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocolJiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
Clinical Pharmacokinetics|March 28, 2014
A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo dataFarzaneh Salem, Trevor N Johnson, Khaled Abduljalil, et al.
Pageof 6